{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:17:17Z","timestamp":1793924237205,"version":"4.8.0"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pulmonary fibrosis is the leading cause of death in systemic sclerosis (SSc). Sirtuin1 (SIRT1) is a deacetylase with known antiinflammatory and antifibrotic activity in the liver, kidney, and skin. The role of SIRT1 in SSc-related pulmonary fibrosis is unknown. In the present work, we determined that the expression of SIRT1 in peripheral blood mononuclear cells of patients with SSc with pulmonary fibrosis is lower than that in patients with SSc without pulmonary fibrosis. In in vivo studies of bleomycin-induced lung fibrosis in mice, SIRT1 activation with resveratrol reduced collagen production when it was administered either prophylactically during the inflammatory stage or after the development of fibrosis. Furthermore, SIRT1 activation or overexpression inhibited tumor necrosis factor-\u03b1\u2013induced inflammatory responses in vitro in human fetal lung fibroblasts, depletion of SIRT1 in fibroblasts enhanced inflammation, and these effects were related to changes in the acetylation of NF-\u03baB. In addition, SIRT1 activation or exogenous overexpression inhibited collagen production in vitro, and these manipulations also inhibited fibrosis via inactivation of transforming growth factor-\u03b2\/mothers against decapentaplegic homolog and mammalian target of rapamycin signaling. Taken together, our results show that a loss of SIRT1 may participate in the pathogenesis of SSc-related pulmonary fibrosis, and that SIRT1 activation is an effective treatment for both the early (inflammatory) and late (fibrotic) stages of pulmonary fibrosis. Thus, SIRT1 may be a promising therapeutic target in the management of SSc-related pulmonary fibrosis.<\/jats:p>","DOI":"10.1165\/rcmb.2016-0192oc","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T14:50:28Z","timestamp":1502463028000},"page":"28-39","source":"Crossref","is-referenced-by-count":74,"title":["Sirtuin1 Protects against Systemic Sclerosis\u2013related Pulmonary Fibrosis by Decreasing Proinflammatory and Profibrotic Processes"],"prefix":"10.1093","volume":"58","author":[{"given":"Haiyan","family":"Chu","sequence":"first","affiliation":[{"name":"State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Jiang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmei","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences"},{"name":"Division of Dermatology, Huashan Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyun","family":"Ma","sequence":"additional","affiliation":[{"name":"Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Zhu","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Shanghai Medical College and Huashan Hospital, and"},{"name":"Institute of Rheumatology, Immunology, and Allergy, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minrui","family":"Liang","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Shanghai Medical College and Huashan Hospital, and"},{"name":"Institute of Rheumatology, Immunology, and Allergy, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangguang","family":"Shi","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Ding","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences"},{"name":"Medical Laboratory Center, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhou","sequence":"additional","affiliation":[{"name":"University of Texas\u2013McGovern Medical School, Houston, Texas; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejian","family":"Zou","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Shanghai Medical College and Huashan Hospital, and"},{"name":"Institute of Rheumatology, Immunology, and Allergy, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Qian","sequence":"additional","affiliation":[{"name":"Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip W.","family":"Shaul","sequence":"additional","affiliation":[{"name":"Center for Pulmonary and Vascular Biology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jin","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiucun","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences"},{"name":"Institute of Rheumatology, Immunology, and Allergy, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,1]]},"reference":[{"key":"2026012222024486200_bib1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10067-012-2145-7","article-title":"Clinical and serological features of systemic sclerosis in a Chinese cohort","volume":"32","author":"Wang","year":"2013","journal-title":"Clin Rheumatol"},{"key":"2026012222024486200_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/BOR.0b013e32833ddcc9","article-title":"Recent advances in pulmonary fibrosis: implications for scleroderma","volume":"22","author":"Homer","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"2026012222024486200_bib3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/art.1780280706","article-title":"Pulmonary involvement in systemic sclerosis (scleroderma)","volume":"28","author":"Steen","year":"1985","journal-title":"Arthritis Rheum"},{"key":"2026012222024486200_bib4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1472-6882-14-224","article-title":"Dissection of the mechanism of traditional Chinese medical prescription\u2013Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis","volume":"14","author":"Wu","year":"2014","journal-title":"BMC Complement Altern Med"},{"key":"2026012222024486200_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-pathol-012513-104706","article-title":"Pathogenesis of idiopathic pulmonary fibrosis","volume":"9","author":"Wolters","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"2026012222024486200_bib6","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/art.38702","article-title":"Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?","volume":"66","author":"Herzog","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2026012222024486200_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11926-009-0071-8","article-title":"Pathogenesis of pulmonary fibrosis in systemic sclerosis: lessons from interstitial lung disease","volume":"12","author":"Veraldi","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"2026012222024486200_bib8","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1172\/JCI60323","article-title":"Pulmonary fibrosis: patterns and perpetrators","volume":"122","author":"Noble","year":"2012","journal-title":"J Clin Invest"},{"key":"2026012222024486200_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1164\/rccm.201207-1204PP","article-title":"Mesenchymal stem cells and idiopathic pulmonary fibrosis: potential for clinical testing","volume":"188","author":"Toonkel","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222024486200_bib10","first-page":"145","article-title":"The role of cytokines in human lung fibrosis","volume":"51","author":"Vaillant","year":"1996","journal-title":"Monaldi Arch Chest Dis"},{"key":"2026012222024486200_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1465-9921-12-41","article-title":"Adrenomedullin in inflammatory process associated with experimental pulmonary fibrosis","volume":"12","author":"Di Paola","year":"2011","journal-title":"Respir Res"},{"key":"2026012222024486200_bib12","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20110551","article-title":"Integrating mechanisms of pulmonary fibrosis","volume":"208","author":"Wynn","year":"2011","journal-title":"J Exp Med"},{"key":"2026012222024486200_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev.biochem.73.011303.073651","article-title":"The Sir2 family of protein deacetylases","volume":"73","author":"Blander","year":"2004","journal-title":"Annu Rev Biochem"},{"key":"2026012222024486200_bib14","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1039\/C4CS00373J","article-title":"The chemical biology of sirtuins","volume":"44","author":"Chen","year":"2015","journal-title":"Chem Soc Rev"},{"key":"2026012222024486200_bib15","doi-asserted-by":"crossref","first-page":"H1375","DOI":"10.1152\/ajpheart.00053.2015","article-title":"The role of sirtuins in cardiac disease","volume":"309","author":"Matsushima","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026012222024486200_bib16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/acel.12342","article-title":"Longevity and skeletal muscle mass: the role of IGF signalling, the sirtuins, dietary restriction and protein intake","volume":"14","author":"Sharples","year":"2015","journal-title":"Aging Cell"},{"key":"2026012222024486200_bib17","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jaci.2014.09.035","article-title":"Loss of sirtuin 1 (SIRT1) disrupts skin barrier integrity and sensitizes mice to epicutaneous allergen challenge","volume":"135","author":"Ming","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2026012222024486200_bib18","doi-asserted-by":"crossref","first-page":"e27081","DOI":"10.1371\/journal.pone.0027081","article-title":"Activation of Sirt1 by resveratrol inhibits TNF-\u03b1 induced inflammation in fibroblasts","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"key":"2026012222024486200_bib19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.joca.2012.11.017","article-title":"SIRT1, a class III histone deacetylase, regulates TNF-\u03b1\u2013induced inflammation in human chondrocytes","volume":"21","author":"Moon","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"2026012222024486200_bib20","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.2337\/db11-0616","article-title":"SirT1 regulates adipose tissue inflammation","volume":"60","author":"Gillum","year":"2011","journal-title":"Diabetes"},{"key":"2026012222024486200_bib21","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/art.39061","article-title":"The histone deacetylase sirtuin 1 is reduced in systemic sclerosis and abrogates fibrotic responses by targeting transforming growth factor \u03b2 signaling","volume":"67","author":"Wei","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2026012222024486200_bib22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/annrheumdis-2014-205740","article-title":"Sirt1 regulates canonical TGF-\u03b2 signalling to control fibroblast activation and tissue fibrosis","volume":"75","author":"Zerr","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2026012222024486200_bib23","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jcb.24748","article-title":"Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-\u03b2\/Smad3 pathway","volume":"115","author":"Huang","year":"2014","journal-title":"J Cell Biochem"},{"key":"2026012222024486200_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2015.12.008","article-title":"SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy","volume":"205","author":"Cappetta","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026012222024486200_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.taap.2015.09.028","article-title":"Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion","volume":"289","author":"Wu","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"key":"2026012222024486200_bib26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2026012222024486200_bib27","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1172\/JCI10531","article-title":"Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice","volume":"106","author":"Hattori","year":"2000","journal-title":"J Clin Invest"},{"key":"2026012222024486200_bib28","doi-asserted-by":"crossref","first-page":"27610","DOI":"10.1038\/srep27610","article-title":"Salvianolic acid B attenuates experimental pulmonary fibrosis through inhibition of the TGF-\u03b2 signaling pathway","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"2026012222024486200_bib29","doi-asserted-by":"crossref","first-page":"e109589","DOI":"10.1371\/journal.pone.0109589","article-title":"The suppressive effect of resveratrol on HIF-1\u03b1 and VEGF expression after warm ischemia and reperfusion in rat liver","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"2026012222024486200_bib30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/jpet.113.212076","article-title":"Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy","volume":"350","author":"Ponnusamy","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"2026012222024486200_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/0886022X.2013.844644","article-title":"Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction","volume":"36","author":"Liang","year":"2014","journal-title":"Ren Fail"},{"key":"2026012222024486200_bib32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s12272-010-0415-y","article-title":"The protective effect of resveratrol on dimethylnitrosamine-induced liver fibrosis in rats","volume":"33","author":"Hong","year":"2010","journal-title":"Arch Pharm Res"},{"key":"2026012222024486200_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/BST0350281","article-title":"Impact of post-translational modifications of proteins on the inflammatory process","volume":"35","author":"Ito","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"2026012222024486200_bib34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/rccm.200505-717OC","article-title":"Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model","volume":"173","author":"Chaudhary","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222024486200_bib35","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","article-title":"The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?","volume":"40","author":"Moeller","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"2026012222024486200_bib36","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1038\/jid.2015.252","article-title":"Dual mTOR inhibition is required to prevent TGF-\u03b2\u2013mediated fibrosis: implications for scleroderma","volume":"135","author":"Mitra","year":"2015","journal-title":"J Invest Dermatol"},{"key":"2026012222024486200_bib37","doi-asserted-by":"crossref","first-page":"e0138625","DOI":"10.1371\/journal.pone.0138625","article-title":"mTOR overactivation and compromised autophagy in the pathogenesis of pulmonary fibrosis","volume":"10","author":"Gui","year":"2015","journal-title":"PLoS One"},{"key":"2026012222024486200_bib38","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1471-2466-14-168","article-title":"Clinical significance of mTOR, ZEB1, ROCK1 expression in lung tissues of pulmonary fibrosis patients","volume":"14","author":"Park","year":"2014","journal-title":"BMC Pulm Med"},{"key":"2026012222024486200_bib39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/lrb.2008.1006","article-title":"Efficacy of rapamycin in scleroderma: a case study","volume":"6","author":"Fried","year":"2008","journal-title":"Lymphat Res Biol"},{"key":"2026012222024486200_bib40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jdermsci.2014.02.002","article-title":"Effects of the immunosuppressant rapamycin on the expression of human \u03b12(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts","volume":"74","author":"Tamaki","year":"2014","journal-title":"J Dermatol Sci"},{"key":"2026012222024486200_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13048-014-0097-z","article-title":"SIRT1 activator (SRT1720) improves the follicle reserve and prolongs the ovarian lifespan of diet-induced obesity in female mice via activating SIRT1 and suppressing mTOR signaling","volume":"7","author":"Zhou","year":"2014","journal-title":"J Ovarian Res"},{"key":"2026012222024486200_bib42","doi-asserted-by":"crossref","first-page":"iii40","DOI":"10.1093\/rheumatology\/kep109","article-title":"Pulmonary complications: one of the most challenging complications of systemic sclerosis","volume":"48","author":"Wells","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"2026012222024486200_bib43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.phrs.2012.10.010","article-title":"Negative regulation of inflammation by SIRT1","volume":"67","author":"Xie","year":"2013","journal-title":"Pharmacol Res"},{"key":"2026012222024486200_bib44","doi-asserted-by":"crossref","first-page":"L567","DOI":"10.1152\/ajplung.00308.2006","article-title":"Sirtuin regulates cigarette smoke\u2013induced proinflammatory mediator release via RelA\/p65 NF-\u03baB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging","volume":"292","author":"Yang","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222024486200_bib45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13048-016-0293-0","article-title":"Resveratrol and acetyl-resveratrol modulate activity of VEGF and IL-8 in ovarian cancer cell aggregates via attenuation of the NF-\u03baB protein","volume":"9","author":"Tino","year":"2016","journal-title":"J Ovarian Res"},{"key":"2026012222024486200_bib46","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bjp.0706469","article-title":"The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model","volume":"147","author":"Mart\u00edn","year":"2006","journal-title":"Br J Pharmacol"},{"key":"2026012222024486200_bib47","first-page":"3477","article-title":"Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the I\u03baB kinase","volume":"60","author":"Holmes-McNary","year":"2000","journal-title":"Cancer Res"},{"key":"2026012222024486200_bib48","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2012.04.003","article-title":"SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function","volume":"15","author":"Price","year":"2012","journal-title":"Cell Metab"},{"key":"2026012222024486200_bib49","doi-asserted-by":"crossref","first-page":"22251","DOI":"10.1038\/srep22251","article-title":"Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis","volume":"6","author":"Kessoku","year":"2016","journal-title":"Sci Rep"},{"key":"2026012222024486200_bib50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/pmic.201500171","article-title":"A proteomics approach to identifying key protein targets involved in VEGF inhibitor mediated attenuation of bleomycin-induced pulmonary fibrosis","volume":"16","author":"Kulkarni","year":"2016","journal-title":"Proteomics"},{"key":"2026012222024486200_bib51","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.freeradbiomed.2005.02.036","article-title":"Inhibition of the respiratory burst by resveratrol in human monocytes: correlation with inhibition of PI3K signaling","volume":"39","author":"Poolman","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"2026012222024486200_bib52","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1164\/rccm.2010014","article-title":"Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis","volume":"166","author":"Inoue","year":"2002","journal-title":"Am J Respir Criti Care Med"},{"key":"2026012222024486200_bib53","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1248\/bpb.33.1095","article-title":"Resveratrol inhibits angiogenic response of cultured endothelial f-2 cells to vascular endothelial growth factor, but not to basic fibroblast growth factor","volume":"33","year":"2010","journal-title":"Biol Pharm Bull"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/58\/1\/28\/66467045\/ajrcmb_58_1_28.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/58\/1\/28\/66467045\/ajrcmb_58_1_28.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T03:03:02Z","timestamp":1769137382000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/58\/1\/28\/8430594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,1]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,1]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2016-0192oc","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2018,1,1]]}}}